California Public Employees Retirement System Tcr2 Therapeutics Inc. Transaction History

California Public Employees Retirement System

  • $141 Billion
  • Q1 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021
SELL
$16.41 - $24.71 $848,397 - $1.28 Million
-51,700 Closed
0 $0
Q1 2021

May 14, 2021
SELL
$20.38 - $34.07 $96,641 - $161,559
-4,742 Reduced 8.4%
51,700 $1.14 Million
Q4 2020

Feb 02, 2021
SELL
$19.0 - $32.63 $20,900 - $35,893
-1,100 Reduced 1.91%
56,442 $1.75 Million
Q3 2020

Nov 05, 2020
BUY
$13.1 - $20.69 $321,500 - $507,773
24,542 Added 74.37%
57,542 $1.17 Million
Q2 2020

Aug 12, 2020
BUY
$6.51 - $16.85 $214,830 - $556,050
33,000 New
33,000 $507,000

About TCR2 THERAPEUTICS INC.

TCRR Quotes by TradingView
  • Ticker TCRR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,606,400
  • Description
  • TCR2 Therapeutics Inc., a clinical-stage immunotherapy company, focuses on developing novel T cell receptor (TCR) therapies for patients suffering from cancer. The company's lead product candidates include gavo-cel, a mono TCR Fusion Construct T cells (TRuC-T cells) targeting mesothelin positive solid tumors, which is in phase I/II clinical tria...
More about TCRR
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email